New York State Common Retirement Fund Has $33.53 Million Holdings in Agilent Technologies, Inc. $A

New York State Common Retirement Fund lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 14.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 284,120 shares of the medical research company’s stock after selling 49,503 shares during the quarter. New York State Common Retirement Fund owned approximately 0.10% of Agilent Technologies worth $33,529,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in A. Resona Asset Management Co. Ltd. raised its stake in shares of Agilent Technologies by 6.2% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after acquiring an additional 5,767 shares in the last quarter. TrueMark Investments LLC acquired a new position in Agilent Technologies during the second quarter valued at approximately $1,999,000. Nuance Investments LLC grew its holdings in Agilent Technologies by 13.5% during the second quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock valued at $9,523,000 after purchasing an additional 9,628 shares during the last quarter. Fenimore Asset Management Inc raised its position in shares of Agilent Technologies by 2.7% in the second quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock valued at $21,346,000 after purchasing an additional 4,823 shares during the period. Finally, Asset Management One Co. Ltd. lifted its stake in shares of Agilent Technologies by 3.4% in the second quarter. Asset Management One Co. Ltd. now owns 124,577 shares of the medical research company’s stock worth $14,701,000 after buying an additional 4,152 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 12,490 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the completion of the transaction, the chief executive officer directly owned 33,448 shares in the company, valued at approximately $5,017,200. This represents a 27.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.26% of the company’s stock.

Agilent Technologies Stock Performance

NYSE:A opened at $153.48 on Monday. The firm’s 50-day moving average is $142.44 and its 200-day moving average is $126.88. The company has a market cap of $43.51 billion, a price-to-earnings ratio of 36.03, a PEG ratio of 4.67 and a beta of 1.29. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same period last year, the business earned $1.46 earnings per share. The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be given a dividend of $0.255 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Evercore ISI raised their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research note on Tuesday, October 7th. JPMorgan Chase & Co. upped their price target on shares of Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Rothschild & Co Redburn assumed coverage on Agilent Technologies in a research report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target on the stock. Rothschild Redb raised Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. Finally, Bank of America increased their target price on Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a research note on Tuesday, November 25th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $161.08.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.